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Sideroblastic changes of the bone marrow can be
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INTRODUCTION
The presence of ring sideroblasts (RS) in the bone
marrow aspiration is the hallmark for hereditary and
acquired sideroblastic anemia. Sideroblasts are visible
with Perl’s Prussian blue staining under microscopic
examination of bone marrow. In adult patients, RS
are highly suggestive of a myelodysplastic syndrome
(MDS) or another type of myeloid neoplasm with RS,
when other causes have been ruled out. In acquired
sideroblastic disorders, anemia is usually normo- or
macrocytic with a variable population of hypochromic
red blood cells (RBCs) on the blood smear, and the
occasional presence of circulating erythroblasts.
However, none of these changes in peripheral blood is
distinctive enough to predict the diagnosis of siderob-
lastic anemia.
New generation hematology systems supply essen-
tial information on blood cells, complementing micro-
scopic cell examination. The RBC scatter plots,
generated by the automated ADVIA
 120 hematology
analyzers (Bayer Diagnostics, Tarrytown, NY, USA),
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SUMMARY
The diagnosis of sideroblastic anemia is based on bone marrow
aspiration, and the detection of ring sideroblasts (RS) in iron staining.
The ﬁnding of laboratory parameters to approach this diagnosis still
remains a great challenge. In this study, we analyzed the value of a
speciﬁc erythrogram pattern from peripheral blood, produced by the
ADVIA
 120 cell counter, to predict sideroblastic changes in the bone
marrow. In a two step-design study, we first showed that 32/38
consecutive patients reporting 1 5 %R Sh a ds u c hap a t t e r ni nt h e
erythrogram. In the second step, we prospectively identified over a
period of 32 months 21 patients with this typical erythrogram; 20/21
had 15% RS in the bone marrow. Hence, by this validation, we
confirm that the erythrogram is highly predictive of RS in the bone
marrow. The interpretation of the erythrogram should become daily
practice in hematology to improve the efficacy to detect sideroblastic
changes.
Re-use of this article is permitted in accordance with the
Terms and Conditions set out at http://www3.interscience.
wiley.com/authorresources/onlineopen.html
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based on the volume and hemoglobin concentration.
These erythrograms show a characteristic pattern in
diverse conditions such as iron deﬁciency, thalassemia,
autoimmune hemolytic anemia and spherocytosis, and
their use is valuable in daily practice (Ricerca et al.,
1987; Pati, Patton & Harris, 1989; Macdougall et al.,
1992; d’Onofrio et al., 1992; Robertson et al., 1992;
McKay et al., 1993; Kutter et al., 2002).
We observed a characteristic erythrogram in
patients with sideroblastic anemia, consisting of an
unusual broad scatter distribution of the red cells in
respect of their volume and hemoglobin concentra-
tion, with a substantial number of dots overlapping
onto the hypochromic and the microcytic quadrants.
This erythrogram is clearly distinctive from iron
deﬁciency, megaloblastic anemia or MDS without RS
(Figure 1). We sought to conﬁrm the diagnostic value
(a) 
(c) (d) (e) (f)
(b) 
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(ii) 
Figure 1. The erythrogram is a graphical representation of red blood cells (RBCs) produced by the automated cell
analyzer ADVIA
 120 (Bayer), based on cell by cell measurements of hemoglobin concentration (abscissa), and
red cell volume (ordinate). (a) Diagram of an erythrogram divided into nine areas, according to the red cell
volume and hemoglobin concentration. Normally the erythrocytes are located within the area 1 (normochromic,
normocytic RBC). RBCs located on the left side of the ﬁrst vertical line passing at 280 g/l are hypochromic. RBCs
located on the right side of the second vertical line passing at 410 g/l are hyperchromic. RBCs located above the ﬁrst
horizontal line passing at 120 fL are macrocytic; RBCs located below the second horizontal line, assigned at 60 fL are
microcytic. The erythrogram offers a sensitive and speciﬁc method for detection of minority of RBC populations,
and provides a typical pattern which assists in differentiating between diseases such as iron deﬁciency anemia,
thalassemia minor, and macrocytosis. (b) Patient with sideroblastic anemia: (bi) Iron staining of the bone marrow
cytology with RS. (bii) Erythrogram of peripheral blood from the same patient showing a typical RS-pattern,
with the RBCs largely scattered over eight of nine areas (all except area seven). In comparison erythrograms with
different pattern: (c) normal erythrogram, (d) iron deﬁciency anemia; the RBCs are mainly moved to area four, with
microcytic, hypochromic RBCs, (e) thalassemia minor; the RBCs are moved mainly to area six with microcytic,
normochromic RBCs, and (f) macrocytosis; the RBCs are mainly moved to area ﬁve, with macrocytic,
normochromic RBCs.
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the bone marrow.
DESIGN AND METHODS
This was a single center study with a two step model
design. In the ﬁrst step, we reviewed all reports of
bone marrow cytology performed in the Hematology
Laboratory of the University Hospital of Basel between
January 2004 and June 2006. Any case with 15% RS
in the iron staining (MDS, other myeloid neoplasms, or
reactive forms of sideroblastic anemia) and having a
peripheral blood count performed with an ADVIA
 120
system, were included in the study. These cases were
compared with a control group of 30 patients with a
myeloid neoplasm presenting dysplastic features without
RS. We deﬁned as RS-pattern (Figure 1bii) an erythro-
gram with a broad distribution of the RBCs over nearly
eight of the nine areas of the scattergram (Figure 1a),
with dots spread over the macrocytic, microcytic and
hypochromic areas. All other erythrogram patterns were
considered as non-RS-pattern. The erythrogram as well
as numerical RBC parameters were compared between
both groups.
The second step of the study aimed to validate the
RS-pattern. Therefore, from January 2006 to June
2008, we collected prospectively all cases with a RS-
pattern performed in the Hematology Laboratory and
evaluated their predictive value for sideroblastic
changes in the iron staining of bone marrow cytology.
The Hematology Laboratory operates as a central Lab
for the whole University Hospital, performing a mean
of 600 automated peripheral blood counts daily. For
this second step, the technicians were trained to iden-
tify the RS-pattern during their routine work. From
each newly detected peripheral blood count with a
RS-pattern, a smear of peripheral blood was per-
formed and together with the erythrogram forwarded
to the physician in charge of the laboratory to initial-
ize the required investigations. All patients with repre-
sentative cytology smears of the bone marrow were
included for this analysis in the validation group.
Patients with repetitive evaluations were considered
only once. This study has the approval of our Institu-
tional Review Board.
A Mann–Whitney U-test was used to show numer-
ical differences between groups. In all statistical
procedures, P < 0.05 was considered the level of sig-
niﬁcance. Statistical analysis was performed using
SPSS statistical software (SPSS for Windows, Release
14.0; SPSS, Inc., Chicago, IL, USA).
RESULTS AND DISCUSSION
In the ﬁrst step of the study, 38 cases with newfound
RS in the bone marrow and available ADVIA periph-
eral blood analysis were identiﬁed within 3285 evalu-
ated bone marrow results. Thirty two (84%) of the
38 cases had the typical RS-pattern in the erythro-
gram. In the control group none of the 30 patients
without RS (P < 0.0001) had such a pattern. This
typical RS-pattern has a numerical background
(Table 1). There were signiﬁcant differences in RBC-
indices between patients with and those without RS.
Only few RS-patients showed microcytic (6/38), or
hypochromic anemia (7/38) or had a decreased con-
tent of hemoglobin of the reticulocytes (CHr) (2/38).
These ﬁndings contrast with the high number of RS-
patients with an increased percentage of hypochromic
RBC (hypoRBC). RS-patients showed consistently
3% hypoRBC (26/38, 68%) compared to patients
without RS (7/30; 23%). The combination of
increased hypoRBC and low CHr is usually closely
related to iron deﬁciency (Fishbane et al., 1997, 2001;
Tessitore et al., 2001; Kotisaari et al., 2002; Radtke
et al., 2005). In our cohort with RS, we have the par-
ticular constellation of increased hypoRBC, but nor-
mal CHr (25/26 RS-patients). An increased
percentage of hypochromic erythrocyte has been pre-
viously described in patients with refractory anemia
and RS (Ljung, Back & Hellstrom-Lindberg, 2004;
Murphy et al., 2006). Another constant feature in
patients with RS-pattern was the increased red cell
distribution width (RDW) with values 19% in 22/
38 (58%). In contrast, a RDW 19% was observed
only in 3/30 (10%) patients without RS. Despite sig-
niﬁcant differences found between patients with and
without RS, none of these numerical parameters used
without the erythrogram was useful in the daily
practice to predict sideroblastic changes in the bone
marrow. Indeed, ﬁrst, for each individual parameter,
there was a substantial overlap between patients with
and without RS. Secondly, we looked for a useful
tool in the daily practice allowing to suspect the pres-
ence of RS at ﬁrst sight. None of the numerical
parameters fulﬁlled these criteria.
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A. ROVÓ ET AL. ERYTHROGRAM PATTERN OF SIDEROBLASTIC CHANGES 331Table 1. Patient’s characteristics and RBCs values. In the ﬁrst step analysis, comparison of patients with and without
RS; in the second step analysis, validation with patients presenting a typical RS-pattern
Analysis of the ﬁrst step Second validation step
With RS Without RS
P-value
(with RS vs.
without RS) Validation
P-value (with
RS vs. validation
group)
n 38 30 21
Female/male 18/20 9/21 9/12
Median age (range) 67.5 (23–95) 64 (23–91) 63 (42–85)
Diagnose
AML 6 6 4
NOS 3 – 3
t-myeloid neoplasm – – 1
AML with MLD 3 6 –
MDS 21 21 11
RA – 3 –
RARS 6 – 8
RCMD 9 3 –
RAEB-1 and RAEB-2 6 12 3
del (5q): – 1 –
Unclassiﬁable – 2 –
MPN 3 – 4
CML-AP 2 – 2
PMF 1 – 1
PV – – 1
MDS/MPN 6 3 1
RARS-T 4 – –
CMML: 2 1 –
Unclassiﬁable – 2 1
Others 2 – 1
Hemoglobin, g/l 95 (61–151) 95 (68–144) 0.72 95.5 (80–121) 0.98
MCV, fL 91.2 (75.4–113.7) 99.7 (84–116.7) 0.001 93.6 (78.1–100.7) 0.53
MCH, pg 30.8 (22.8–37) 34.7 (27.6–39.9) 0.0002 31.5 (26.2–36.3) 0.64
MCHC, g/dl 335.5 (265–365) 340.5 (307–367) 0.203 336 (300–346) 0.72
RDW, % 21.4 (14.6–33.8) 17.1 (13.8–28.6) 0.0002 22.6 (19–28) 0.019
hypoRBC,% 5.3 (0.3–78) 1.3 (0.1–21.2) 0.00006 6.7 (3.3–20.9) 0.25
Retic (·10
9/l) 73.6 (9–251) 39.4 (0.5–164.9) 0.002 49.9 (5.4–209.6) 0.14
CHr, pg 33 (25–51) 37 (28–41) 0.002 33.5 (27–38) 0.67
Erythrogram pattern
RS-pattern 32 0 <0.000001 21
Any other pattern 6 30 0
15% of RS in BM 38 0 20
RS, ringed sideroblasts; AML, acute myeloid leukemia; NOS, not otherwise speciﬁed; t-myeloid neoplasm, therapy-
related myeloid neoplasm; AML with MLD, AML with multilineage dysplasia; MDS, myelodysplastic syndromes;
RA, refractory anemia; RARS, refractory anemia with ring sideroblasts; RCMD, refractory cytopenia with multilineage
dysplasia; RAEB-1 and RAEB-2, refractory anemia with excess blasts 1 and 2; del (5q), associated with isolated del
(5q); MPN, myeloproliferative neoplasms; CML-AP, CML BCR-ABL1 positive in accelerated phase; PMF, primary
myeloﬁbrosis; PV, polycythemia vera; RARS-T, RARS associated with marked thrombocytosis; CMML, chronic myelo-
monocytic leukemia; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular
hemoglobin concentration; RDW, red cell distribution width; hypoRBC, hypochromic erythrocyte; Retic, absolute
reticulocytes; CHr, content of hemoglobin of the reticulocytes; BM, bone marrow cytology.
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a RS-pattern (2 Acute myeloid leukemia, 2 MDS/
myeloproliferative neoplasms, 1 MDS, 1 hemophago-
cytosis). All six patients had increased iron stores,
5/6 were anemic and did not have the typical numeri-
cal parameters (4/6 high MCV; 5/6 < 20% RDW;
5/6 < 1.1% hypoRBC).
In the second step of the study, we compared the
validation group with the initial RS-patients. We iden-
tiﬁed prospectively 28 cases with a RS-pattern; 7/28
cases were excluded because they had a dry tap in the
bone marrow aspiration. We found RS in the bone
marrow of 20/21 evaluable cases, with a median of
50% RS (range 15–75%) Figure 2. All of them had
increased iron stores. The patient with a typical RS-
pattern, but without RS in the bone marrow, had
depleted iron stores. As expected, RBC-indices of both
groups were similar (P > 0.10) (Table 1). Hence, by
Figure 2. Erythrograms of all 20 patients of the validation group with a typical RS-pattern and ringed sideroblasts in
the bone marrow.
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erythrogram is highly predictive of RS in the bone
marrow.
Siderotic granulations within the mitochondria
form the hallmark of RS. Aspirate smears represent
the gold standard for assessing RS. Mitochondrial iron
is dissolved during treatment with chelation and
decalciﬁcation agents. Therefore, RS remain unstained
in parafﬁn sections obtained by decalciﬁed tissue.
They can only be identiﬁed in undecalciﬁed material
of plastic sections or with the use of special staining
techniques (Tham & Cousar, 1993). Thus, in patients
with ﬁbrosis and dry tap in marrow aspiration, side-
roblastic changes can be easily missed when no special
attention is brought. According to our results, even in
patients with dry tap, we can assume the presence of
sideroblastic changes when patients have a typical
RS-pattern. Moreover, if erythroblasts are present in
peripheral blood, an iron staining could support this
assumption by detecting circulating RS.
We demonstrated here the value of the erythro-
gram as a simple diagnostic tool in the routine labo-
ratory analysis. It works as a ‘ﬁngerprint’ and can
evoke a diagnosis at ‘ﬁrst look’ and consequently
drive the investigations to conﬁrm our suspicion.
Despite that, a size distribution histogram allows
identifying dimorphic red blood cell populations, a
two dimensional erythrogram has a great speciﬁcity
for suspecting sideroblastic changes. As sideroblastic
anemia is frequently a normocytic, normochromic
anemia, it can be easily misinterpreted with anemia of
chronic disorder. Nine of 21 patients from the valida-
tion group presented normocytic and normochromic
anemia without neutropenia and thrombocytopenia.
In these patients, the erythrogram (RS-pattern) was a
strong argument to think about an underlying
myeloid neoplasms and to perform a bone marrow
investigation. As for iron deﬁciency, thalassemia or
macrocytosis, the erythrogram pattern has also a
great visual impact to detect sideroblastic changes.
Additionally, the RS-pattern is supported by the com-
bination of the following RBC-indices: normal MCV
and MCHC, RDW 19%, hypoRBC 3% and normal
CHr.
In conclusion, this is the ﬁrst study evaluating sys-
tematically the value of the erythrogram of peripheral
blood as a diagnostic tool in daily practice to predict
sideroblastic changes in the bone marrow. These
results conﬁrm the great value of the erythrogram as
part of the routine evaluation of peripheral blood
count.
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